Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Cancer

Sunbeds should be banned in the UK to cut skin cancer rates, experts say

Exposure to ultraviolet radiation from sunbeds was confirmed to be carcinogenic to humans in 2009 by the International Agency for Research on Cancer.

The Independent UK

Sick Of It All singer Lou Koller says his oesophageal cancer has returned

The hardcore vocalist was first diagnosed with the disease in summer 2024 and said he was cancer-free in May

Metal Hammer

Sanofi Expands Insulin Savings Program To Cover All US Patients

The U.S. Food and Drug Administration removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa (vandetanib), a thyroid cancer medication manufactured by Sanofi SA’s (NASDAQ: SNY) Genzyme Corporation.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Three in four English hospitals failing to hit two cancer targets in league tables

Exclusive: Cancer experts declare ‘national emergency’ as hospitals miss targets on diagnosis and starting treatment

The Guardian - UK

Warning after cancer patients died following delays in getting life-saving emergency drugs

More than a dozen cancer patients have either died or become seriously ill after not getting rasburicase

The Independent UK

EXCLUSIVE: Hoth Therapeutics' Antisense Therapy Demonstrates Efficacy Against KIT-Driven Cancers

Hoth Therapeutics Inc. (NASDAQ:HOTH) on Tuesday announced combined findings from multiple preclinical programs evaluating its precision antisense candidate HT-KIT.

Benzinga

HCW Biologics' Shares Surge After Unveiling Next-Gen Cancer Immunotherapy Platform

HCW Biologics Inc. (NASDAQ:HCWB) stock is trading higher on Monday, with a session volume of 10.85 million compared to the average volume of 132.51K as per data from Benzinga Pro.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Thousands referred for liver cancer checks after on-the-spot scan

Some 112,831 people have had a mobile scan of their liver under the NHS scheme

The Independent UK

Treatment that can double bladder cancer survival rates available to 1,000 patients in England

People with disease that has spread have been found to live twice as long when given treatment hailed as ‘hopeful’

The Guardian - UK

Abortion drug could help reduce risk of breast cancer, group of medics says

Stigma around mifepristone is stopping studies, experts in reproductive health claim in Lancet opinion piece

The Guardian - UK

Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients

On Tuesday, Merck Co. Inc. (NYSE:MRK) released topline results from the Phase 3 KEYNOTE-905 trial (also known as EV-303) in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based chemotherapy.

Benzinga

IO Biotech's Combo Therapy For Skin Cancer Falls Just Short, Eyes FDA Talks Later This Year

IO Biotech (NASDAQ:IOBT) on Monday released topline results from the pivotal Phase 3 trial of its investigational, immune-modulatory, off-the-shelf therapeutic cancer vaccine, Cylembio (imsapepimut and etimupepimut, adjuvanted).

Benzinga

Three new cancer drugs approved for use for NHS Scotland

Three new treatments for cancer have been approved for use by the NHS in Scotland ...

The National (Scotland)

The new take-at-home drug that ‘could boost effectiveness of chemotherapy’

New medicine will spare some patients from more aggressive treatments

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

‘Game-changing’ cancer vaccine trial to begin on NHS

The jab uses mRNA technology to train the immune system to fight cancerous cells

Evening Standard

Patients to be fast-tracked on to new head and neck cancer vaccine trial

The jab uses mRNA technology to train the immune system to fight cancer.

Benzinga

Celcuity Stock Skyrockets On Breakthrough Trial Data For Heavily Pretreated Breast Cancer

Celcuity Inc. (NASDAQ:CELC) stock surged on Monday after the company reported topline results from the PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial, which evaluated gedatolisib plus fulvestrant with and without palbociclib versus fulvestrant.

The Independent UK

Alcohol labels should warn of cancer risk, urge health groups

Doctors and health experts have written a letter to Sir Keir Starmer urging the government to tackle a lack of awareness about the links between alcohol consumption and cancer

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Alcohol should have labels warning drinkers of cancer risks, charities say

Health organisations have written to Keir Starmer urging him to force drinks producers to include warnings

International Business Times UK

Banned in Britain, Still on US Shelves: Jolly Ranchers Pulled Over 'Cancer‑Causing' Ingredients

Jolly Rancher sweets have been pulled from UK shelves over ingredients linked to cancer risk. Here's why the US still allows them and what consumers need to know

The Independent UK

EPA will revisit Biden-era ban on the last type of asbestos used in US

The Environmental Protection Agency will reconsider a Biden administration ban on the last type of asbestos used in the United States

The Guardian - UK

UK-wide drug trial hailed as a ‘milestone’ in leukaemia treatment

Combination of two targeted drugs found to produce better outcomes and was more tolerable than chemotherapy

The Independent UK

‘Milestone’ treatment could reshape future leukaemia care

The Flair trial found that 94 per cent of patients who received the two targeted drugs were alive with no disease progression after five years

Evening Standard

New leukaemia treatment hailed as ‘milestone’ for patients

After five years, 94% of patients were alive, with no disease progression.

The Independent UK

NHS green lights ‘Trojan horse’ treatment that attacks cancer cells from inside

One early adopter describes how he was in remission ‘within the first two or three weeks’ after the treatment

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

The Environmental Protection Agency

the University of Leeds

62 stories

CTSI

57 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.